Compare AROW & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AROW | CTKB |
|---|---|---|
| Founded | 1851 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 727.7M | 777.3M |
| IPO Year | 1995 | 2021 |
| Metric | AROW | CTKB |
|---|---|---|
| Price | $36.84 | $6.29 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $43.25 | $6.50 |
| AVG Volume (30 Days) | 54.1K | ★ 1.2M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | ★ 49.72 | N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | $26.52 | $3.83 |
| Revenue Next Year | $15.02 | $6.48 |
| P/E Ratio | $21.04 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $29.11 | $3.31 |
| 52 Week High | $42.70 | $6.34 |
| Indicator | AROW | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 38.01 | 61.83 |
| Support Level | $35.48 | $4.10 |
| Resistance Level | $37.88 | N/A |
| Average True Range (ATR) | 0.94 | 0.37 |
| MACD | -0.23 | 0.01 |
| Stochastic Oscillator | 9.62 | 98.07 |
Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.